TikTok hasn't announced a peptide ban, but since October 20, 2026, searches for specific peptide names, including BPC-157, retatrutide and semaglutide, have returned "No results found". Searching the general word "peptides" still worked, and The Verge found no sign of mass video removals. Some creators say their videos were taken down or their accounts banned. TikTok had not explained the change when we checked on October 21, 2026.
Notice: Research peptides are sold for in-vitro laboratory research only. They are not FDA-approved, not for human or animal consumption, and this page is not medical advice. We report what platforms and regulators do; we don't help anyone get around a platform's rules.
What's blocked and what isn't
Based on reports from October 20-21, 2026:
| Search or content | What users saw |
|---|---|
| "bpc-157" | "No results found" (Jeff Tang on X, via The Source; confirmed by The Verge, per EEW Magazine) |
| "retatrutide", "semaglutide" | "No results found" (The Verge, per EEW Magazine and Mezha) |
| "melanotan" | "No results found" (The Source) |
| "reta" | Eating-disorder support resources (The Source) |
| "peptides" (general) | Still returned videos (Mezha) |
| Existing videos | No sign of mass deletion, per The Verge; some creators report removals and account bans |
So far, the change is mostly about search. A video posted before October 20 may still exist, but it's harder to find. Search results on TikTok can differ by region and account, and they may change again.
What TikTok has said
Nothing specific to peptides, as of October 21, 2026:
- TikTok did not immediately respond to The Verge's request for comment, per EEW Magazine.
- Responding to an earlier Forbes investigation (October 7) into weight-loss and peptide advertising, TikTok called the reporting false and said it prohibits deceptive advertising and keeps strengthening enforcement, per the same report.
- TikTok's community guidelines already prohibit promoting high-risk drugs and certain weight-loss products. Searches that are blocked usually fall under that kind of policy, but TikTok hasn't said which rule applies here.
Claims that TikTok "officially banned all peptide content" come from social media posts, not from TikTok.
Why now: the backdrop
TikTok hasn't given a reason, so these are the events around the change, not a confirmed cause:
- Peptide content had exploded. Monthly searches for "peptides" rose from about 201,000 in April 2025 to over 1.2 million in March 2026, per market research cited by EEW Magazine. Researchers writing in The Conversation counted more than 230 million views of peptide content on TikTok.
- Affiliate selling and code words. Physician Céline Gounder documented sellers recruiting creators with discount-code commissions, and creators using words like "peppers" and "pep" to avoid moderation.
- Safety reports. CBS News reported on October 13, 2026 that two deaths had been reported to FDA in people who took products sold as retatrutide, and that America's Poison Centers logged 862 retatrutide exposures in the three months to September 2026 (Becker's). FDA hasn't said whether it verified those reports.
- Lilly's crackdown on retatrutide sellers. Eli Lilly has sued 11 sellers since August 2026 and says it has reported more than 14,000 websites, ads, posts and listings to platforms (Lilly). See our Eli Lilly peptide lawsuits page.
- FDA enforcement. FDA sent warning letters to "research use only" sellers in March, June and August 2026, treating products marketed for human use as unapproved drugs (our regulatory tracker).
Did Eli Lilly do this? One influencer posted a video blaming Lilly, per Mezha. We found no evidence for it. Lilly's public requests to platforms were about removing specific listings selling retatrutide, and neither company has linked them to TikTok's search change.
The regulatory picture is pulling the other way
TikTok's move comes as the federal government considers loosening access to some peptides through pharmacies:
- In July 2026, FDA's compounding advisory committee voted to recommend six peptides, including BPC-157, for the 503A bulks list (our tracker).
- On October 15, 2026, HHS sent an "interim access policy" for peptides to the White House for review. It could let pharmacies temporarily compound some popular peptides, including BPC-157, under FDA enforcement discretion. Details haven't been published (STAT).
None of this changes the status of research-use-only vials: they're sold for lab research, not approved for human use. See are peptides legal? and FDA peptide regulation in 2026.
What it means if you research peptides
- Expect less peptide content on TikTok, and more of what remains to use code words, which makes it harder to judge. Code names are also a red flag FDA has cited in warning letters.
- Don't treat social videos as evidence. Product claims in creator videos are often affiliate marketing. Check a vendor's lab reports instead: our COA guide and COA checklist explain what to look for.
- Compare vendors on testing, not hype. Our vendor directory rates every vendor on published COAs, named labs, independent Finnrick tests and red flags, and our price index shows what peptides cost.
Last checked October 21, 2026. We'll update this page if TikTok explains the change or reverses it.
